Pharma focus asia

1 / 12Email: adver [email protected] Tel: +91 40 4961 4567 Fax +91 40 4961 4555 www.pharmafocusasia.com

A mAgAzine for phArmA industry leAdersstrategy

research & development

manufacturing

Clinical trials

information technology

mediA pACK 2014


the mArKet trendWith a lot of mergers and acquisitions taking place in the Asian markets, and growth being the primary objective of the Asian pharma industry, it has become evident that the centre stage of global pharma operations is shifting from the us and europe to Asia.

Constrained with patent expiries and cost pressures, the biggies of the pharma industry are looking towards the Asian markets to offshore a variety of services from drug discovery to manufacturing.

the VoiCe . . .Pharma Focus Asia, a biannual print publication, provides a unique opportunity to bring your products and services to the attention of key budget holders within the largest pharmaceutical organisations around the world. this publication is made available only to a select group of decision makers who represent a spending power of us$350 billion. that money is more and more likely to be heading towards Asia and europe, and you should make sure you get your share.


Why phArmA foCus AsiA?there is a huge market in Asia for european products and vice versa. getting your message across to the major players in these markets is very difficult, unless you have Pharma Focus Asia and its resources working for you in a consistent manner, in the right direction. only top pharma companies across the world are targeted by Pharma Focus Asia that has articles and insights contributed by leading industry experts.

the readers of Pharma Focus Asia appreciate the publication because they recognise the value of its independent reporting and the quality of its content. it clearly makes Pharma Focus Asia a powerful prospect for advertisers.

the publication is circulated over 13,500 hard copies and more than 100,000 e-book copies. this translates into an estimated readership base of 187,000 (source: publisher’s survey).

Pharma Focus Asia is distributed across Asia pacific, the middle east, europe and north America.


tArget mArKetPharma Focus Asia directs the senior management in capturing market share. our readers represent the leading players in the Asian pharma market and the top global players, who are your target market. And our dedicated team of researchers ensures that the distribution list is unrivalled in its quality and reach. the readers of Pharma Focus Asia have requested to receive the publication because they recognise the value of its independent reporting. taking a closer look at the quality of writing and the journalistic integrity, it clearly makes Pharma Focus Asia a powerful prospect for readers.

Business Segments

others

12%Biophamaceutical

9%

information technology

8%

Cro and Cmo

8%packaging

5%

manufacturers

58%

rest of the World

1%America

7%

europe

30%Asia pacific

62%

Geographical Distribution


tArget AudienCePharma Focus Asia’s qualified and thoroughly researched circulation ensures that your advertisement reaches the right people in the right companies. only the most influential decision-makers, C-level executives, senior management and key decision makers in charge of spending from the top pharmaceutical companies in Asia and rest of the world, receive Pharma Focus Asia.

delivering reliable and accurate coverage of the pharma industry’s progress, Pharma Focus Asia helps its readers make informed decisions to stay ahead of the competition.

Businessmanagement

50%research and development

10%

manufacturing

14%

others

4%

C-level

22%

Readership Distribution


3m Co•Aarti drugs ltd•Abbott india ltd•Alcon inc•Allergan inc•Amersham plc•Amgen inc•Astrazeneca plc•Aventis pasteur msd sa•Bausch & lomb inc•Baxter international inc•Bayer group•Boehringer ingelheim•Bristol-myers squibb Co•Chiron Corporation•daiichi pharmaceutical Co•dr reddy’s•eisai Co•eli lilly & Co•forest laboratories inc•genentech inc•genzyme Corp•glaxosmithKline•ipca laboratories ltd•Johnson & Johnson•Kyowa hakko Kogyo Co•lupin ltd•

merck & Co•mitsubishi pharma Corp•morepen laboratories ltd•novartis•novo nordisk As•pfizer inc•procter & gamble Co•roche•ranbaxy laboratories•limited•sankyo Co•schering Ag•schering-plough Corp•serono sA•shionogi & Co•taisho pharmaceutical Co•takeda Chemical•industries ltd•Wockhardt limited•tanabe seiyaku Co•teva pharmaceutical•industries ltd•morepen laboratories ltd•tyco international ltd•Wockhardt limited•Wyeth•

Principal Job FunctionsCorporate management•research & development•Business development•manufacturing & processing•Control & Assurance•packaging•purchasing•licensing•finance•marketing / sales•regulatory Affairs Quality•production management•process engineering•

CirCulAtion detAils

A partial list of companies whose executives are subscribers of PFA Countriespharma focus Asia is an international title and will be sent out across the usA, europe and Asia. Countries in Asia that will receive the publication include:

China•hong Kong•india•indonesia•Japan•malaysia•Korea•pakistan•philippines•singapore•taiwan•thailand•


editoriAlAll articles in Pharma Focus Asia are written either by leading industry experts or based on the views of business leaders. Pharma Focus Asia is dedicated to bringing its readers accurate coverage that is independent and incisive. it will enable industry leaders to make informed decisions.

editorial mix comprises of articles in the following areas:

StRateGy

ReSeaRch & Development

manufactuRinG

clinical tRialS

infoRmation technoloGy

for the editorial content of the current issue, go to: http://www.pharmafocusasia.com/magazine/

eDitoRial contRiButoRS

Alan S Louie Research Director, Health Industry Insights, an IDC Company, USA

Christopher-Paul Milne Associate Director, Tufts Center for the Study of Drug Development, Tufts University

Douglas Meyer Senior Director, Aptuit Informatics Inc.

Georg C Terstappen Chief Scientific Officer, Siena Biotech S.p.A., Italy

Frank A Jaeger Director, New Business Development, Solvay Pharmaceuticals, Inc., USA

Kenneth I Kaitin Director and Professor of Medicine, Tufts Center for the Study of Drug Development, Tufts University, USA

Laurence Flint Associate Director, Clinical Research, Schering-Plough Research Institute

Neil J Campbell CEO, Mosaigen Inc. and Partner, Endeavour Capital Asia Ltd., USA

Phil Kaminsky Founder, Center for Biopharmaceutical Operations, University of California, Berkeley, USA

Rustom Mody Director, Quality and Strategic Research, Intas Biopharmaceuticals Limited, India

Sanjoy Ray Director, Technology Innovation, Merck Research Laboratories, USA

Alan Fisher Contamination Control Specialist, Dycem USA Limited, USA

Brian D Smith Managing Director, Pragmedic, UK

Rajneesh Kumar Gaur Scientist ‘C’, Department of Biotechnology, Ministry of Science & Technology, New Delhi, India


Reasons to adveRtise with us

CirCulation: A meticulously crafted circulation database of companies that matter to you – A market place custom-built to your needs

readership: readers are carefully chosen top executives. A judicious blend of purchase decision makers and specifiers - the individuals who matter most to your company

Valuable Content: insights and incisive analysis of industry dynamics and emerging trends in technologies including drug discovery, manufacturing etc., written by the leading experts

online presenCe: listing on the search engine optimised website - print advert doubling-up as online vehicle

in sum, targeted marketing translating into ‘value for money’

1

2

3

4

5


AdVertising rAtes

CuSToM PuBLIShINGIn addition to the standard advertising options mentioned, we also undertake custom publishing POA

Please contact at [email protected] to discuss advertising and custom publishing opportunities

The publication is a high design, full colour publication 210mm wide x 297mm deep. In order to maximise the impact, a strictly limited number of advertising positions have been made available.

Note:1. Advertisers are provided with one

copy of the publication only.2. Requirement for extra copies

needs to be indicated at the time of approving the advert. Such copies entail extra charges @ $10 per copy, plus cost of delivery

3. The above ad tariff is exclusive of the Ad agency commission

4. Corporate Showcase (8-pages) option entails flash of your logo on the cover page bottom part (Size: 20 mm X 35 mm).

5. Font “Adobe Garamond Pro” is not allowed for the contents of corporate showcase.

ADveRTISING oPTIoNS .........RATeS (IN uSD)

Double Page Spread .............................. $8,900

Full Page ............................................... $4,500

Half Page .............................................. $2,450

1/3rd Page Vertical Outer ...................... $1,475

1/3rd Page Product Flash ..................... $750

CoveR PoSITIoNS

Outside Front Cover ............................... $6,900

Inside Front Cover ................................. $5,800

Inside Back Cover ................................. $5,800

SPeCIAL PoSITIoNS

1. Corporate Showcase

A. 8-Pages, with flash on front cover ... $27,500

B. 4-Pages .......................................... $14,850

2. Gatefold

A. Cover: 2-Pages ............................... $10,850

B. Inner: 2-Pages ................................ $10,500

3. Island ............................................... $6,500

BANNeR TyPe DIMeNSIoNS (px) MAx FILe SIze FILe FoRMAT RATeS (uSD)

Prime Banner 800x220 50kb GIF, JPEG, Flash SWF $8,500

Leader Board Banner 728x90 40kb GIF, JPEG, Flash SWF $6,500

Sky Tower Banner 120x600 40kb GIF, JPEG, Flash SWF $5,500

Top/Full Banner 468x60 30kb GIF, JPEG, Flash SWF $4,500

Base Banner 468x60 30kb GIF, JPEG, Flash SWF $3,000

Vertical Half Banner 120x240 25kb GIF, JPEG, Flash SWF $2,500

Rectangular Banner 234x60 15kb GIF, JPEG, Flash SWF $2,200

BANNeR TyPe DIMeNSIoNS (px) MAx FILe SIze FILe FoRMAT RATeS (uSD)

Leader Board Banner 728x90 40kb GIF, JPEG, Flash SWF $2,000

Top/Full Banner 468x60 30kb GIF, JPEG, Flash SWF $1,500

Article / Interview 800 words MS Word $1,000

DIReCT MARKeTING

Pricing StructureDirect Marketing campaigns are charged per e-mail address and the cost is (US $0.20) per address, for mail shots above 15,000 units. For mail shots below 15,000 units, the charge is (US$0.25) Booking example:10,000 Direct Marketing messages cost: 10,000 x US$0.25 = US $2,500

RATe CARD FoR PRINT RATe CARD FoR WeBSITe

RATe CARD FoR e-NeWSLeTTeR


hALF PAGe hoRIzoNTAL

Depth (A) Width (B)Half page horizontal 124mm X 178mm

DouBLe PAGe SPReAD

Depth (A) Width (B)Double page type 255mm X 380mm Double page trim 297mm X 420mmDouble page bleed 303mm X 432mm

FuLL PAGe

Depth (A) Width (B)Full page type 255mm X 178mm Full page trim 297mm X 210mmFull page bleed 303mm X 216mm

(B)

(A) (A)

(B)

(A)

(B)

1/3RD PAGe veRTICAL ouTeR

Depth (A) Width (B)1/3rd Page Vertical Outer 237mm X 52mm

(A)

(B)

1/6Th PAGe PRoDuCT FLASh

Depth (A) Width (B)1/6th Page Product Flash 70mm X 82mm

(A)(B)

ISLAND

Depth (A) Width (B)1/3rd Page Vertical Outer 80mm X 52mm

(A)(B)

meChAniCAl detAilsGATeFoLD CoveR 2-PAGeS

ARTWoRKSoFTWARe: InDesign, Photoshop, Illustrator & High resolution PDF (file must have all images at 300dpi with fonts embedded) (Not Compatible: PageMaker, CorelDraw or any other software or files from the Internet)

PICTuRe ReSoLuTIoN: 300dpi at 100% scaling for images, either as TIFF, JPG, EPS, or PDF

CoLouR: All colours to be CMYK breakdowns, including InDesign, Illustrator and Photoshop files

FoNTS: Include all print and screen fonts

Depth (A) Width (B)Gatefold Cover 2-Pages type 255mm X 380mm Gatefold Cover 2-Pages trim 297mm X 420mmGatefold Cover 2-Pages bleed 303mm X 432mm

CoverPage

Gatefold Cover2-Pages

(B)

(A)Gatefold Cover

2-Pages

GATeFoLD INNeR 2-PAGeS

Page-1Page-2

(B)

(A)

Depth (A) Width (B)Gatefold Inner 2-Pages type 255mm X 380mm Gatefold Inner 2-Pages trim 297mm X 420mmGatefold Inner 2-Pages bleed 303mm X 432mm


CLIeNTeLe LIST KNoWLeDGe PARTNeRS MeDIA PARTNeRS


teRmS & conDitionS CONDITIONS SET OUT IN THE JOINT AGREEMENT FOR ADVERTISEMENT

1. SCoPe oF ouR AGReeMeNT: These are the conditions of the contract between you, the client (“you” and “your”) and Ochre Media (“Ochre Media”, “we”, “us” and “our”) relating to the provision by us of advertising space in the magazine, as specified on your purchase order.

2. CoNTeNT AND ARTWoRK ReSPoNSIBILITy: You are respon-sible for providing all text and illustrations (“copy material”) for your advertisement/s and any other insert/s (“advertisement”) in such a format as Ochre Media may specify by the copy deadline specified on your purchase order.

We shall prepare a proof of your advertisement and send across to you for approval. If you wish to change any element of it, you must send your changes to Ochre Media by the return date shown on the proof. If we have not received any changes by the return date, we will assume that you have approved the proof.

If you fail to supply copy material by the copy deadline, Ochre Media reserves the right to repeat standing copy or to independently determine the copy to be published (including sourcing from the pub-lic domain). Failure by you to supply the necessary copy material for your advertisement by the copy deadline will not affect your obligation to pay for the advertisement in accordance with clause 4 below.

If your copy material is provided in a form different from that specified then you will be responsible for any reasonable extra costs that may arise for preparing the material.

Notwithstanding the above, you agree that Ochre Media shall at all times retain full editorial approval over the advertisement and that, except as expressly provided in your purchase order, the positioning of the advertisement shall be at Ochre Media’s sole discretion. Ochre Media reserves the right at its absolute discretion to reject, withdraw or amend text/information supplied by you for the advertisement and such will not affect your obligation to pay for the advertisement in full in accordance with clause 4.

3. RIGhTS: In consideration of Ochre Media providing its adver-tising, marketing and design services to you, you assign to Ochre Media full title guarantee, for use throughout the world, the copyright (whether vested, contingent or future) in the copy material supplied by you and all rights of action in respect of that copy material.

The above will not operate as an assignment of your trade marks,

service marks and logos which will remain your property. Accordingly, you hereby grant to Ochre Media a worldwide, non-exclusive, fully paid licence to reproduce and display all trademarks, service marks and logos contained within the copy material for the duration of this contract.

4. INvoICe AND SeTTLeMeNT: An invoice for the amount specified in your purchase order (plus applicable taxes) will be issued at the time your advertisement is first published.

We will then invoice you for each renewed period (as defined in clause 7) at Ochre Media’s then current rates on or shortly after the relevant anniversary of the date of first publication. You may request a copy of the rates that will apply in any renewed period from Ochre Media at any time within three calendar months before the commence-ment of that renewed period.

Settlement of all invoices is due 14 days from the date of the in-voice. If your account falls overdue, then interest will be charged at the rate of 12% per annum. This will be calculated on a daily basis from the due date to the actual payment date. All prices quoted in the purchase order are exclusive of applicable taxes.

5. WARRANTy AND INDeMNITy: You warrant and represent to Ochre Media that: (i) you have all necessary rights to grant the rights and li-cences set out in this contract to Ochre Media; (ii) neither the copy ma-terial provided by you nor any material which may be linked to through your advertisement will contain anything that is defamatory, obscene, false or misleading or which otherwise violates any intellectual property rights or other rights of any person; (iii) use of the copy material pro-vided by you will not violate any applicable law or regulation.

You agree to indemnify and keep indemnified Ochre Media and hold Ochre Media harmless against any and all damages, costs or fees aris-ing from a breach of the above warranties including any claim or action by a third party.

6. LIABILITy: Ochre Media does not accept any liability for any dam-ages (including, without limitation, damages for any consequential loss or loss of business opportunities or projects, or loss of profits) how-soever arising and whether in contract, tort or otherwise from the use of or inability to use the advertisement, or any of its contents, or from any action or omission taken as a result of using the advertisement or any such contents. Ochre Media does not exclude liability for death or personal injury arising out of its negligence.

You agree that Ochre Media has not made any guarantees with re-spect to usage statistics, which include, without limitation, levels of impressions or click-throughs for the advertisement.

7. CANCeLLATIoN: This contract represents a legally binding com-mitment between you and Ochre Media. You may only cancel your ad-vertisement and terminate this contract in accordance with clause 7 or, prior to the date your advertisement is first published, with the written consent of Ochre Media. Ochre Media’s consent will be at its sole and absolute discretion. If Ochre Media consents, prior to the date your advertisement is first published, to your advertisement being cancelled and this contract being terminated you will be liable to pay at least 50% of the amount specified in your purchase order (plus applicable taxes) and such amount will become payable within 14 days following the date of Ochre Media’s written consent.

8. GeNeRAL: You may not resell, assign or transfer any of your rights under this contract without Ochre Media’s prior written consent. Any at-tempt to resell, assign or transfer rights without Ochre Media’s consent will entitle Ochre Media to terminate this contract immediately without liability to you.

A person who is not a party to this contract has no right to rely upon or enforce any terms of this contract. In the event of a dispute arising out of or in connection with these terms or any contract between you and us, then you agree to attempt to settle the dispute by engaging in good faith with us in a process of mediation before commencing arbi-tration in accordance with The Arbitration and Conciliation Act, 1996.

This agreement is governed by and will be construed in accor-dance with laws of India and each party irrevocably agrees that the courts of Hyderabad shall have the exclusive jurisdiction to deal with any disputes arising out of or in connection with this agreement. These terms and conditions along with the purchase order constitute the entire agreement and understanding between you and Ochre Media and su-persede any previous agreement between the parties. You agree that all the details of this contract appear in the purchase order and these terms and conditions and that no employee of Ochre Media has made any promise or commitment to you that does not appear here. Both parties agree that the terms and conditions described here are binding and may only be varied in writing signed by you and by a director of Ochre Media. Nothing in this contract shall operate to limit or exclude liability for fraud. Printed terms and conditions in any additional documents issued by you or your agent will not be recognised as binding.

Healthcare

Pharma focus asia